Dental Care Clinics in Jay, FL Accepting Medicare
1 Dental Care Clinics found. Showing 1 - 1
 Jimmie D Lassiter Dmd Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 5285 Commerce St, Jay, FL 32565 Phone: 850-675-8545 |
News Archive
Fighting against treatment-resistant opioid use disorder
Similar to treatment resistant depression, there is a subpopulation of those addicted to opioids who do not respond to standard opioid use disorder (OUD) treatments.
Study reports IL-37's activity in the adaptive immune system
A University of Colorado Cancer Center study published in this month's Proceedings of the National Academy of Sciences describes the activity of a recently discovered communication molecule of the body's immune system, Interleukin 37 or IL-37. It has been known to limit inflammation and the current study reports its activity in the adaptive immune system: IL-37 inhibits the ability of the immune system to recognize and target new antigens.
Study links colic, maternal depression to family problems
Some families with new babies face excessive infant crying, or colic. And some new mothers go through maternal post-partum depression (PPD) following childbirth. Neither situation is considered healthy, but a recent study published in the Infant Mental Health Journal has found that the combined impact of colic and PPD can have a highly toxic outcome. Researchers have linked colicky babies and maternal depression to decrease in overall family functioning.
FDA grants Novian Health IDE approval for Novilase ILT System to treat breast cancer
Novian Health, developer of Novilase® Breast Therapy, announced that the US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval for the company to start a multi-center study of its Novilase® Interstitial Laser Therapy (ILT) System. Novian developed the ILT System for the ablation of small (up to 20 mm) malignant breast tumors.
Trabedersen granted orphan drug designation from both FDA And EMEA for treating pancreatic carcinoma
The biopharmaceutical company Antisense Pharma GmbH has announced today that it has received orphan drug designation from both the European Medicines Agency EMEA and the US Food and Drug Administration FDA for its investigational drug trabedersen in the treatment of pancreatic carcinoma.
› Verified 3 days ago